ArticleFrontiers in immunology2022

Case report: Safety and efficacy of adalimumab in treating difficult-to-treat rheumatoid arthritis in a human immunodeficiency virus-positive patient, one year follow-up.

Jing-Wen Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.